X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (136) 136
Publication (31) 31
Book / eBook (20) 20
Book Review (8) 8
Conference Proceeding (7) 7
Dissertation (7) 7
Book Chapter (4) 4
Journal / eJournal (1) 1
Newspaper Article (1) 1
Patent (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (81) 81
humans (52) 52
animals (33) 33
female (26) 26
male (25) 25
article (21) 21
research (20) 20
mice (18) 18
oncology (14) 14
analysis (13) 13
cancer (13) 13
adolescent (11) 11
abridged index medicus (10) 10
adult (10) 10
cell biology (10) 10
expression (10) 10
health aspects (10) 10
middle aged (10) 10
physiological aspects (10) 10
genetics (9) 9
in-vivo (9) 9
research article (9) 9
risk factors (9) 9
tumors (9) 9
united states (9) 9
angiogenesis (8) 8
biochemistry & molecular biology (8) 8
cell line, tumor (8) 8
gene expression (8) 8
genes (8) 8
genetic aspects (8) 8
proteins (8) 8
psychiatry (8) 8
aged (7) 7
biological sciences (7) 7
climate change (7) 7
diagnosis (7) 7
evolution (7) 7
history (7) 7
management (7) 7
multidisciplinary sciences (7) 7
cells (6) 6
genetics & heredity (6) 6
psychology (6) 6
signal transduction (6) 6
spectroscopy (6) 6
surgery (6) 6
apoptosis (5) 5
astronomy & astrophysics (5) 5
astrophysics (5) 5
biology (5) 5
fluorescence (5) 5
genetic research (5) 5
growth (5) 5
metastasis (5) 5
natural sciences (5) 5
naturvetenskap (5) 5
prevalence (5) 5
prevention (5) 5
proteasome endopeptidase complex - metabolism (5) 5
rats (5) 5
smoking (5) 5
tumor-growth (5) 5
ubiquitin - metabolism (5) 5
usage (5) 5
youth (5) 5
adolescents (4) 4
aged, 80 and over (4) 4
antiangiogenic therapy (4) 4
antineoplastic agents - pharmacology (4) 4
bibliography (4) 4
biochemistry, genetics and molecular biology (4) 4
biological evolution (4) 4
biologiska vetenskaper (4) 4
blood-vessels (4) 4
breast neoplasms - metabolism (4) 4
breast neoplasms - pathology (4) 4
cardiac & cardiovascular systems (4) 4
care and treatment (4) 4
collagen (4) 4
degradation (4) 4
disease models, animal (4) 4
ecology (4) 4
endothelial growth-factor (4) 4
evolutionary biology (4) 4
galaxy astrophysics (4) 4
genomes (4) 4
genotype & phenotype (4) 4
heart failure (4) 4
medicine, research & experimental (4) 4
mice, inbred c57bl (4) 4
mice, knockout (4) 4
optics (4) 4
pharmacology & pharmacy (4) 4
phenotype (4) 4
plants (4) 4
political science (4) 4
populus - genetics (4) 4
radiology, nuclear medicine & medical imaging (4) 4
religion (4) 4
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (9) 9
UTL at Downsview - May be requested (8) 8
Gerstein Science - Stacks (3) 3
UofT at Scarborough - Stacks (3) 3
Collection Dvlpm't (Acquisitions) - Vendor file (2) 2
St. Michael's College (John M. Kelly) - 2nd Floor (2) 2
Trinity College (John W Graham) - Reference (2) 2
UofT at Mississauga - Stacks (2) 2
Victoria University E.J. Pratt - Reference (2) 2
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Gerstein Science - Reference (1) 1
Institute for Christian Studies - Stacks (1) 1
Massey College (Robertson Davies) - Rare Book (1) 1
OISE - Storage (1) 1
Trinity College (John W Graham) - Periodical Stacks (1) 1
Victoria University E.J. Pratt - Periodical Stacks (1) 1
Victoria University E.J. Pratt - Virginia Woolf (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 4/2016, Volume 113, Issue 16, pp. 4476 - 4481
Inhibition of the vascular endothelial growth factor (VEGF) pathway has failed to improve overall survival of patients with glioblastoma (GBM). We previously... 
Anti-angiogenic therapy | Macrophage polarization | Tumor microenvironment | Microglia reprogramming | Anti-tumor immunity | anti-angiogenic therapy | BEVACIZUMAB | MULTIDISCIPLINARY SCIENCES | macrophage polarization | RANDOMIZED-TRIAL | ANGIOPOIETIN-2 | CANCER | THERAPY | microglia reprogramming | TIE2-EXPRESSING MONOCYTES | BLOOD-VESSELS | TUMOR-ASSOCIATED MACROPHAGES | tumor microenvironment | NORMALIZATION | anti-tumor immunity | ENDOTHELIAL GROWTH-FACTOR | Macrophages - pathology | Antibodies, Bispecific - pharmacology | Vesicular Transport Proteins - metabolism | Humans | Neoplasm Proteins - antagonists & inhibitors | Vascular Endothelial Growth Factor A - metabolism | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Neoplasm Proteins - metabolism | Neoplasms, Experimental - pathology | Xenograft Model Antitumor Assays | Macrophages - metabolism | Vesicular Transport Proteins - antagonists & inhibitors | Animals | Antibodies, Neoplasm - pharmacology | Ribonuclease, Pancreatic - metabolism | Glioblastoma - pathology | Cell Line, Tumor | Glioblastoma - metabolism | Antineoplastic Agents - pharmacology | Mice | Neoplasms, Experimental - metabolism | Glioblastoma - drug therapy | Ribonuclease, Pancreatic - antagonists & inhibitors | Neoplasms, Experimental - drug therapy | Viral antibodies | Care and treatment | Antibodies | Physiological aspects | Models | Macrophages | Vascular endothelial growth factor | Health aspects | Glioblastoma multiforme | Genotype & phenotype | Survival analysis | Protein expression | Cells | Tumors | Cancer | Index Medicus | Biological Sciences
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 4/2016, Volume 113, Issue 16, pp. 4470 - 4475
Glioblastomas (GBMs) rapidly become refractory to anti-VEGF therapies. We previously demonstrated that ectopic overexpression of angiopoietin-2 (Ang-2)... 
Anti-angiogenic therapy | Colony-stimulating factor 1 | Tumor immunity | Tumor microenvironment | Macrophage | anti-angiogenic therapy | ANGIOPOIETIN-2 FUNCTIONS | ANGIOGENESIS | MULTIDISCIPLINARY SCIENCES | macrophage | BEVACIZUMAB PLUS IRINOTECAN | RANDOMIZED-TRIAL | ANTIBODY | tumor immunity | KINASE INHIBITOR | ANTIANGIOGENIC THERAPY | PHASE-II TRIAL | colony-stimulating factor 1 | tumor microenvironment | EXPRESSION | ENDOTHELIAL GROWTH-FACTOR | Macrophages - pathology | Neoplasm Proteins - antagonists & inhibitors | Neoplasm Proteins - metabolism | Neovascularization, Pathologic - pathology | Neoplasms, Experimental - pathology | Macrophages - metabolism | Animals | Antibodies, Neoplasm - pharmacology | Receptors, Vascular Endothelial Growth Factor - metabolism | Ribonuclease, Pancreatic - metabolism | Neovascularization, Pathologic - drug therapy | Glioblastoma - pathology | Cell Line, Tumor | Receptors, Vascular Endothelial Growth Factor - antagonists & inhibitors | Glioblastoma - metabolism | Mice | Neovascularization, Pathologic - metabolism | Neoplasms, Experimental - metabolism | Glioblastoma - drug therapy | Quinazolines - pharmacology | Ribonuclease, Pancreatic - antagonists & inhibitors | Neoplasms, Experimental - drug therapy | Drug Screening Assays, Antitumor | Survival analysis | Gene expression | Kinases | Cells | Tumors | Cancer | Index Medicus | Biological Sciences
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 04/2015, Volume 107, Issue 4, p. 1
Background: Matrix metalloproteinase (MMP) 14 may mediate tumor progression through vascular and immune-modulatory effects. Methods: Orthotopic murine breast... 
VASCULAR NORMALIZATION | INVASION | CANCER CELLS | ANGIOGENESIS | ONCOLOGY | MATRIX-METALLOPROTEINASE INHIBITORS | DRUG-DELIVERY | NITRIC-OXIDE SYNTHASE | TUMOR-GROWTH | EXPRESSION | BETA | Up-Regulation | Immunoglobulin G - blood | Breast Neoplasms - immunology | Humans | Gene Expression Regulation, Neoplastic | Neovascularization, Pathologic | Antibodies, Monoclonal - therapeutic use | Antineoplastic Agents - therapeutic use | Smad3 Protein - metabolism | Breast Neoplasms - metabolism | Nitric Oxide Synthase Type II - antagonists & inhibitors | Dose Fractionation | Female | Antineoplastic Agents - pharmacology | Matrix Metalloproteinase 14 - drug effects | Antibodies, Monoclonal - pharmacology | Enzyme Inhibitors - pharmacology | Smad2 Protein - metabolism | Nitric Oxide Synthase Type II - drug effects | Breast Neoplasms - blood supply | Matrix Metalloproteinase 14 - metabolism | Breast Neoplasms - drug therapy | Enzyme Inhibitors - therapeutic use | Macrophages - enzymology | Gene Expression Regulation, Enzymologic | Breast Neoplasms - radiotherapy | Phenotype | Animals | Signal Transduction - drug effects | Mammary Neoplasms, Experimental | Cell Line, Tumor | Macrophages - drug effects | Amidines - pharmacology | Mice | Benzylamines - pharmacology | Transforming Growth Factor beta - metabolism | Nitric Oxide Synthase Type II - metabolism | Enzymes | Genotype & phenotype | Immunoglobulins | Immunology | Radiation therapy | Gene expression | Tumors | Index Medicus
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 08/2013, Volume 105, Issue 16, pp. 1188 - 1201
Journal Article
JOURNAL OF CELL BIOLOGY, ISSN 0021-9525, 06/2018, Volume 217, Issue 6, pp. 1941 - 1955
Journal Article
Journal Article
Journal Article
Cell, ISSN 0092-8674, 02/2013, Volume 152, Issue 5, pp. 1065 - 1076
Journal Article